VRS
RYTM icon

Virginia Retirement Systems’s Rhythm Pharmaceuticals RYTM Stock Holding History

Virginia Retirement Systems’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$985K Buy
9,200
+2,500
+37% +$265K 0.01% 585
2025
Q3 		$677K Buy
+6,700
New +$622K ﹤0.01% 693
2023
Q1 		– Sell
-8,000
Closed -$233K – 1207
2022
Q4 		$233K Buy
+8,000
New +$206K ﹤0.01% 1026
2022
Q1 		$136K Buy
+11,800
New +$104K ﹤0.01% 1078

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virginia Retirement Systems's RYTM Position: Q4 2025 in Review

Virginia Retirement Systems increased its Rhythm Pharmaceuticals (RYTM) stake by 37% in Q4 2025, buying an estimated $265K and bringing the position to 9,200 shares worth $985K. The position accounts for 0.01% of the portfolio, ranked #585.

Virginia Retirement Systems first reported a position in RYTM in Q1 2022 and has held it in 4 quarters since. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • Virginia Retirement Systems held 9,200 shares of Rhythm Pharmaceuticals worth $985K as of Q4 2025.
  • Virginia Retirement Systems bought 2,500 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $265K.
  • Rhythm Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #585 holding.
  • Virginia Retirement Systems first reported a position in Rhythm Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.